Trial intelligence / Profile preview

Opioid-sparing vs Sevoflurane Anesthesia in Bariatric Surgery

NCT05962671Phase 4Unknown

Sponsor
Tanta University
Start
Aug 2023
Primary completion
Mar 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine, propofol and ketamine in obesity (2 arms), sponsored by Tanta University. Primary endpoint: Incidence of Early postoperative hypoventilation at 24 hours. Status: unknown.

02

Drugs

dexmedetomidinepropofolketamine
03

Conditions

obesity

Beyond the preview

Go deeper on NCT05962671.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05962671.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call